65 results
424B3
KANT
Kineta, Inc.
13 Nov 23
Prospectus supplement
5:28pm
to recruit and enroll suitable patients in our clinical trials;
the potential attributes and benefits of our product candidates;
our ability to develop
424B5
c3jnymvxzap57zn 8j
5 Oct 23
Prospectus supplement for primary offering
10:47am
8-K
EX-99.1
2i5p l1p9
11 Aug 23
Kineta Reports Second Quarter 2023 Financial Results and Provides Corporate Update
4:03pm
424B3
08osrjbt5
12 Jun 23
Prospectus supplement
5:01pm
424B5
xxe2y619
21 Apr 23
Prospectus supplement for primary offering
5:14pm
8-K
EX-99.5
kd5jpoc
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
424B3
ji51mow
10 Nov 22
Prospectus supplement
4:21pm